2021, doi:10.3389/fendo.2021.721135 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
A recent GLP-1 medicine sold as Mounjaro and Zepbound also works on a second target, the GIP receptor
For persistent symptoms, intra-articular corticosteroid injections or duloxetine may be appropriate adjunctive therapies
E Glycemic goals for some older adults might reasonably be relaxed, using individual criteria, but hyperglycemia leading to symptoms or risk of acute hyperglycemic complications should be avoided in all patients
[14] This was a 6 week tightly controlled study but other long term studies in free living individuals like the CARMEN study have demonstrated the same thing: sugar does not cause significantly less fat loss or more fat gain when calories are equated between diets
However, like all medications, they may give you unwanted side effects